Noteworthy things — Week 14 (01/04/2024)

Thanks to all who gave feedback last week on my first attempt to assemble reading lists of noteworthy things in the field of microbiome, microbial ecology and other generalities! I’ll attempt to add more comments this week, perhaps this could be good Of course, this is all subjective and personal but hopefully interesting to some? 🙂

Studies of interest

(a) Microbiome

  • Infant microbes and metabolites point to childhood neurodevelopmental disorders.
    Angelica P. Ahrens et al. Cell — 3 April 2024.
    Comment: Very exhaustive and impressive study! Using the All Babies in Southeast Sweden (ABIS) cohort, a birth cohort with 20 years follow-up (n=16,440; with n=1,197 developing an ND), these authors show that microbes and associated metabolites in infants contribute to future neurodevelopmental disorders (NDs) (other contributors to higher ND risk are preterm birth, infection, stress, parental smoking and a specific HLA variant). Other results include early-life otitus lowering Coprococcus sp. and increasing Citrobacter sp. in future NDs, potentially once again highlighting the role of early infection in incident disease risk/development.

  • Microbial composition associated with biliary stents in patients undergoing pancreatic resection for cancer.
    Aitor Blanco-Míguez et al. npj Biofilms and Microbiomes — 30 March 2024.
    Comment: Intriguing observation! Authors examined biliary stents from pancreatic cancer patients and found that 17 of 36 prevalent stent species are also common oral microbiome members, associate with disease conditions when present in the gut, and include dozens of biofilm- and AMR-related genes. Not a lot is hypothesised yet on the origin of these microbes or the infection route…

  • An in-depth evaluation of metagenomic classifiers for soil microbiomes.
    Niranjana Rose Edwin et al. Environmental Microbiome (19) — 28 March 2024.
    Comment: Interesting benchmarking study looking at various different conditions and classifiers with mock soil metagenomic datasets, with the conclusion: “Our findings suggest that employing Kraken2 with Bracken, coupled with a custom database of GTDB-TK genomes and fungal genomes at a relative abundance threshold of 0.001% provides optimal accuracy in soil shotgun metagenome analysis.“. It somehow mirrors what we have been using (among other things) in our group for metagenomics classification, with the tweaking of confidence parameters for Kraken2.

  • A metagenomics pipeline reveals insertion sequence-driven evolution of the microbiota.
    Joshua M. Kirsch et al. Cell Host & Microbes — 01 April 2024.
    Comment: New catalogue and tool to detect IS insertions. Intestinal bacteria have diverse IS insertions maintained over long timescales, which are enriched in accessory genes, such as susCD/tonB transporters. IS insertion activity seems to be affected by perturbations like nutrients and phage.

(b) Microbial ecology, evolution and AMR

  • The emergence of artemisinin partial resistance in Africa: how do we respond?
    Philip J Rosenthal et al. The Lancet Infectious Diseases — 26 March 2024.
    Comment: A very concerning prospect: “Major priorities at present are the expansion of genomic surveillance for ART-R mutations across the continent, more frequent testing of the efficacies of artemisinin-based regimens against uncomplicated and severe malaria in trials, more regular assessment of ex-vivo antimalarial drug susceptibilities, consideration of changes in treatment policy to deter the spread of ART-R, and accelerated development of new antimalarial regimens to overcome the impacts of ART-R.

  • Archaeal actins and the origin of a multi-functional cytoskeleton.
    Arthur Charles-Orszag et al. Journal of Bacteriology — 23 February 2024.
    Comment: Interesting minireview (with absolutely stunning figures) if you are also puzzled about the variability and prevalence of actin-like proteins in microbes (over 40 classes found in bacterial genomes and plasmids, remarkably divergent compared to eukaryotes). The current hypothesis supported by this review is for an engulfment model for eukaryogenesis, where archaeal membrane protrusions encircling a bacterial partner eventually fused to produce an archaeal host cell with a stably engulfed bacterial endosymbiont. Cool stuff!

(c) Other general interest

  • Complexity of avian evolution revealed by family-level genomes.
    Josefin Stiller et al. Nature — 1 April 2024.
    Comment: Very important paper for those with an interest in birds (like I do)! The approach is something quite nice that we had somehow also done for bacteria in some early studies (but not on that scale at all!): in this study, authors reconstructed local phylogenies at 150,000 loci from 363 avian species, building thousands of species trees and test the impact of data quantity and taxon sampling. They found many incongruences of these local trees with the species trees (great examples here from a second paper from some of the authors published in PNAS on the same day), suggesting gene dynamics at the family-level. Not entirely surprising when you know bird, ring species and how promiscuous bird ecology can be sometimes. Very cool stuff!

  • Association of Coffee Consumption and Prediagnostic Caffeine Metabolites With Incident Parkinson Disease in a Population-Based Cohort.
    Yujia Zhao, Yunjia Lai et al. Neurology — 21 March 2024.
    Comment: Caffeine consumption (mainly through 2 metabolites, paraxanthine and theophylline) has been indicated to play a significant role in reducing risk of PD, as well as mitigating PD symptoms in animal models. In this study, authors looked at a population-based 20y-long longitudinal cohort across 6 European countries (EPIC4PD study) to show that coffee consumption inversely correlated with risk of developing PD. Those who consumed the highest amounts of coffee exhibited ~40% lower risk of PD compared to coffee non-consumers.

Promising preprints:

Other interesting things:

  • Interesting advice for group leaders/academics from GV Pavan Kumar on Twitter.
  • Great piece in Nature News about “How does a cancer vaccine work?”. It would seem that “[a]fter decades of slow progress, therapeutic vaccines that direct the immune system to attack tumours could soon become a fixture of cancer treatment“.
  • There is a Klebsiella Virtual Seminar Series if you are interested in hearing talks on the topic. Times aren’t great for Australian researchers but still interesting! More information here.